In the News

The Situation: Many pharmaceutical companies are increasingly focused on developing strategies that will enable them to realize the benefits of using mobile health and digital biomarker data collection technology on clinical trials. Sponsors are challenged to keep pace with the rate of change amidst the rapid emergence of new devices, solutions, and vendors, to understand what capabilities exist, and to implement those capabilities in an effective, efficient, and compliant manner.